CytomX Therapeutics (CTMX) Capital Expenditures Growth (5y) (2019 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | CytomX Therapeutics | 638.18 Mn | 291.48 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -37.61% |
| Sep 30, 2025 | 32.45% |
| Jun 30, 2025 | -6.11% |
| Mar 31, 2025 | -35.29% |
| Dec 31, 2024 | 37.70% |
| Sep 30, 2024 | -61.95% |
| Jun 30, 2024 | 15.63% |
| Mar 31, 2024 | -42.53% |
| Dec 31, 2023 | 16.67% |
| Sep 30, 2023 | -61.40% |
| Jun 30, 2023 | -9.84% |
| Mar 31, 2023 | -42.31% |
| Dec 31, 2022 | -9.99% |
| Sep 30, 2022 | 48.38% |
| Jun 30, 2022 | -16.87% |
| Mar 31, 2022 | 26.19% |
| Dec 31, 2021 | -35.04% |
| Sep 30, 2021 | 31.99% |
| Jun 30, 2021 | -34.59% |
| Mar 31, 2021 | 24.60% |
| Dec 31, 2020 | 29.35% |
| Sep 30, 2020 | -35.02% |
| Jun 30, 2020 | -45.84% |
| Mar 31, 2020 | 32.69% |
| Dec 31, 2019 | -40.95% |